(Q42925886)

11 November 2017

title

Correlation of plasma resistin with obesity and insulin resistance in type 2 diabetic patients (English)

1 reference

11 November 2017

1 reference

M. Y. Gharibeh

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20739208

23 June 2024

G. M. Al Tawallbeh

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20739208

23 June 2024

M. M. Abboud

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20739208

23 June 2024

A. Radaideh

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20739208

23 June 2024

A. A. Alhader

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20739208

23 June 2024

O. F. Khabour

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20739208

23 June 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20739208

23 June 2024

publication date

23 August 2010

1 reference

full work available at URL

11 November 2017

https://api.elsevier.com/content/article/PII:S1262363610001436?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/J.DIABET.2010.05.003

https://api.elsevier.com/content/article/PII:S1262363610001436?httpAccept=text/plain

23 June 2024

1 reference

https://api.crossref.org/works/10.1016/J.DIABET.2010.05.003

23 June 2024

published in

Diabetes and Metabolism

1 reference

11 November 2017

volume

36

1 reference

11 November 2017

issue

6 Pt 1

1 reference

11 November 2017

page(s)

443-449

1 reference

Diagnosis and classification of diabetes mellitus

11 November 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1016/J.DIABET.2010.05.003

23 June 2024

Obesity and diabetes

2

1 reference

https://api.crossref.org/works/10.1016/J.DIABET.2010.05.003

The interrelationship between insulin secretion and action in type 2 diabetes mellitus with different degrees of obesity: evidence supporting central obesity

23 June 2024

3

1 reference

https://api.crossref.org/works/10.1016/J.DIABET.2010.05.003

Should adipokines be considered in the choice of the treatment of obesity-related health problems?

23 June 2024

4

1 reference

https://api.crossref.org/works/10.1016/J.DIABET.2010.05.003

Resistin - concentrations in persons with type 2 diabetes mellitus and in individuals with acute inflammatory disease.

23 June 2024

5

1 reference

https://api.crossref.org/works/10.1016/J.DIABET.2010.05.003

Role of resistin in insulin sensitivity in rodents and humans

23 June 2024

6

1 reference

https://api.crossref.org/works/10.1016/J.DIABET.2010.05.003

Resistin- and Obesity-associated metabolic diseases

23 June 2024

7

1 reference

https://api.crossref.org/works/10.1016/J.DIABET.2010.05.003

Serum Resistin (FIZZ3) Protein Is Increased in Obese Humans

23 June 2024

8

1 reference

https://api.crossref.org/works/10.1016/J.DIABET.2010.05.003

Plasma resistin, adiponectin and leptin levels in lean and obese subjects: correlations with insulin resistance

23 June 2024

10

1 reference

https://api.crossref.org/works/10.1016/J.DIABET.2010.05.003

The hormone resistin links obesity to diabetes

23 June 2024

11

1 reference

https://api.crossref.org/works/10.1016/J.DIABET.2010.05.003

Increased serum resistin levels in patients with type 2 diabetes are not linked with markers of insulin resistance and adiposity

23 June 2024

12

1 reference

https://api.crossref.org/works/10.1016/J.DIABET.2010.05.003

Relationship between serum resistin concentrations and insulin resistance in nonobese, obese, and obese diabetic subjects

23 June 2024

13

1 reference

https://api.crossref.org/works/10.1016/J.DIABET.2010.05.003

Visfatin/PBEF/Nampt and resistin expressions in circulating blood monocytes are differentially related to obesity and type 2 diabetes in humans

23 June 2024

14

1 reference

https://api.crossref.org/works/10.1016/J.DIABET.2010.05.003

Cross-sectional associations of resistin, coronary heart disease, and insulin resistance

23 June 2024

15

1 reference

https://api.crossref.org/works/10.1016/J.DIABET.2010.05.003

An increase in prevalence of diabetes mellitus in Jordan over 10 years

23 June 2024

16

1 reference

https://api.crossref.org/works/10.1016/J.DIABET.2010.05.003

Prediction of lean body mass from height and weight

23 June 2024

17

1 reference

https://api.crossref.org/works/10.1016/J.DIABET.2010.05.003

Continuous infusion of glucose with model assessment: measurement of insulin resistance and beta-cell function in man.

23 June 2024

18

1 reference

https://api.crossref.org/works/10.1016/J.DIABET.2010.05.003

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

23 June 2024

19

1 reference

https://api.crossref.org/works/10.1016/J.DIABET.2010.05.003

Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity.

23 June 2024

20

1 reference

https://api.crossref.org/works/10.1016/J.DIABET.2010.05.003

Enzyme-linked immunosorbent assay for circulating human resistin: resistin concentrations in normal subjects and patients with type 2 diabetes

23 June 2024

21

1 reference

https://api.crossref.org/works/10.1016/J.DIABET.2010.05.003

Resistin and type 2 diabetes: regulation of resistin expression by insulin and rosiglitazone and the effects of recombinant resistin on lipid and glucose metabolism in human differentiated adipocytes

23 June 2024

22

1 reference

https://api.crossref.org/works/10.1016/J.DIABET.2010.05.003

Circulating resistin levels are not associated with obesity or insulin resistance in humans and are not regulated by fasting or leptin administration: cross-sectional and interventional studies in normal, insulin-resistant, and diabetic subjects

23 June 2024

23

1 reference

https://api.crossref.org/works/10.1016/J.DIABET.2010.05.003

Body fat mass and macronutrient intake in relation to circulating soluble leptin receptor, free leptin index, adiponectin, and resistin concentrations in healthy humans.

23 June 2024

24

1 reference

https://api.crossref.org/works/10.1016/J.DIABET.2010.05.003

Identification of variables influencing resistin serum levels in patients with type 1 and type 2 diabetes mellitus.

23 June 2024

25

1 reference

https://api.crossref.org/works/10.1016/J.DIABET.2010.05.003

Removal of visceral fat prevents insulin resistance and glucose intolerance of aging: an adipokine-mediated process?

23 June 2024

26

1 reference

https://api.crossref.org/works/10.1016/J.DIABET.2010.05.003

High serum resistin is associated with an increase in adiposity but not a worsening of insulin resistance in Pima Indians

23 June 2024

27

1 reference

https://api.crossref.org/works/10.1016/J.DIABET.2010.05.003

Serum resistin, adiposity and insulin resistance in Saudi women with type 2 diabetes mellitus.

23 June 2024

28

1 reference

https://api.crossref.org/works/10.1016/J.DIABET.2010.05.003

Serum resistin is associated with C-reactive protein & LDL cholesterol in type 2 diabetes and coronary artery disease in a Saudi population.

23 June 2024

29

1 reference

https://api.crossref.org/works/10.1016/J.DIABET.2010.05.003

Resistin, adiponectin, ghrelin, leptin, and proinflammatory cytokines: relationships in obesity

23 June 2024

30

1 reference

https://api.crossref.org/works/10.1016/J.DIABET.2010.05.003

Regulation of resistin expression and circulating levels in obesity, diabetes, and fasting

23 June 2024

31

1 reference

https://api.crossref.org/works/10.1016/J.DIABET.2010.05.003

Modest weight loss and reduction in waist circumference after medical treatment are associated with favorable changes in serum adipocytokines.

23 June 2024

32

1 reference

https://api.crossref.org/works/10.1016/J.DIABET.2010.05.003

A promoter genotype and oxidative stress potentially link resistin to human insulin resistance

23 June 2024

33

1 reference

https://api.crossref.org/works/10.1016/J.DIABET.2010.05.003

Association of plasma resistin with glomerular filtration rate and albuminuria in hypertensive adults

23 June 2024

34

1 reference

https://api.crossref.org/works/10.1016/J.DIABET.2010.05.003

Elevated resistin levels in chronic kidney disease are associated with decreased glomerular filtration rate and inflammation, but not with insulin resistance

23 June 2024

35

1 reference

https://api.crossref.org/works/10.1016/J.DIABET.2010.05.003

Resistin is an inflammatory marker of atherosclerosis in humans.

23 June 2024

36

1 reference

https://api.crossref.org/works/10.1016/J.DIABET.2010.05.003

Associations between serum resistin levels and insulin resistance, inflammation, and coronary artery disease.

23 June 2024

37

1 reference

https://api.crossref.org/works/10.1016/J.DIABET.2010.05.003

Adipokines: the missing link between insulin resistance and obesity.

23 June 2024

38

1 reference

https://api.crossref.org/works/10.1016/J.DIABET.2010.05.003

23 June 2024

Identifiers

1 reference

11 November 2017

1 reference